Paul Thacker

Most recent articles by Paul Thacker

Taxpayers Need to Cough up the Cash to Keep Federal Agencies Afloat
Taxpayers Need to Cough up the Cash to Keep Federal Agencies Afloat
Paul Thacker
January 8, 2018
12:00 pm

As we continue to debate the proper size and role of government in society, cast your eyes on recent polls by Gallup and Pew that found the majority of Americans felt their income tax was fair.

It’s Time for Trump to Make Good on his Drug Pricing Promises
It’s Time for Trump to Make Good on his Drug Pricing Promises
Paul Thacker
February 6, 2017
12:00 pm

Last week President Trump told drugmakers that ‘the pricing has been astronomical.’

Speeding up FDA Approvals Calls for Pause
Speeding up FDA Approvals Calls for Pause
Paul Thacker
February 3, 2016
12:00 pm

The idea that 30 days is enough time for the FDA to evaluate anything is, of course, quite silly. But Sen. Cruz takes it one step further.

Washington Insider: Drug-Safety Legislation
Washington Insider: Drug-Safety Legislation
Paul Thacker
October 1, 2015
4:00 am

When will the pharma industry resume working with Congress on drug safety?

Washington Insider: Paul Thacker
Washington Insider: Paul Thacker
Paul Thacker
May 1, 2015
4:00 am

After a decade spent stalling, denying and attacking critics, the University of Minnesota has finally admitted some complicity in the death of a patient during a clinical drug trial.

As I See It: Access to data
As I See It: Access to data
Paul Thacker
March 1, 2014
5:00 am

We need for pharmaceutical companies to come forward and make the pledge to stop hiding data

As I See It: Transparency and clinical trial data
As I See It: Transparency and clinical trial data
Paul Thacker
October 1, 2013
4:00 am

By opposing making clinical trial data public, Pharma is once again swimming against the current

As I See It: the Sunshine Act
As I See It: the Sunshine Act
Paul Thacker
April 1, 2013
4:00 am

People in the industry must be worried about the type of care doctors are now giving

As I See It: FDA whistleblower
As I See It: FDA whistleblower
Paul Thacker
August 31, 2012
4:00 am

Companies who submit proprietary data to FDA have a right to ensure it isn’t disclosed to competitors

As I See It: Ghostwriting
As I See It: Ghostwriting
Paul Thacker
April 1, 2012
4:00 am

Apparently, unless the rules explicity prohibit a specific type of unethical behavior, you’re OK

  • From Our Partners